Rafferty Asset Management, LLC 908 Devices Inc. Transaction History

Rafferty Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.0 - $7.24 $120,475 - $174,447	24,095 New	24,095 $124,000
Q3 2023 Nov 13, 2023	SELL	$6.0 - $8.2 $2,652 - $3,624	-442 Reduced 1.2%	36,410 $242,000
Q2 2023 Aug 11, 2023	BUY	$5.78 - $10.02 $213,004 - $369,257	36,852 New	36,852 $252,000
Q2 2022 Aug 12, 2022	SELL	$13.3 - $20.74 $1.01 Million - $1.58 Million	-76,215 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$13.18 - $26.28 $132,379 - $263,956	-10,044 Reduced 11.64%	76,215 $1.45 Million
Q4 2021 Feb 10, 2022	BUY	$23.17 - $38.77 $130,701 - $218,701	5,641 Added 7.0%	86,259 $2.23 Million
Q3 2021 Nov 10, 2021	SELL	$29.99 - $39.13 $255,154 - $332,918	-8,508 Reduced 9.55%	80,618 $2.62 Million
Q2 2021 Aug 10, 2021	BUY	$36.7 - $55.11 $3.27 Million - $4.91 Million	89,126 New	89,126 $3.45 Million

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $61.3M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.